Institute
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
Institute | 09 January 2012
-
Agilent Technologies supports research at the Broad Institute
Developing proteomics technology to detect disease biomarkers.
Institute | 12 October 2011
-
Pharmacyclics collaborates with National Cancer Institute to develop Btk inhibitor
Pharmacyclics, Inc announced the signing of a five-year cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765. This is a first-in-class, small molecule inhibitor…
Institute | 10 August 2011
-
Merck, Serum Institute to develop and expand access to pneumococcal conjugate vaccine
Merck and Serum Institute of India Limited announced an agreement to work together to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries. It is estimated that one out of every two c…
Institute | 04 August 2011
-
Ascletis announces new support from Hangzhou, China and The Hamner Institutes
Ascletis to establish US research and development center at The Hamner Campus.
Institute | 21 July 2011
-
VaxyGen Vaccines announces strategic collaboration with The Serum Institute of India
VaxyGen Vaccines Ltd announced the signing of a strategic collaboration agreement with the Serum Institute of India (SII). Under the terms of the agreement, VaxyGen Vaccines Ltd will have exclusive rights to commercialize certain SII approved and pip…
Institute | 29 June 2011
-
PPD and Southern Research Institute Sign Agreement for Clinical Research Services
PPD and Southern Research Institute have formed a collaborative agreement in pandemic and seasonal influenza vaccine research and development. This is to provide clients a full spectrum of influenza vaccine development services by collaborating on cl…
Institute | 24 March 2010
-
VBI Researchers Develop Method for Breast Cancer Biomarker Discovery
Researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a one-step bioanalytical approach that allows them to profile complex cellular extracts of proteins. The method has allowed the scientists to l…
Institute | 03 July 2009
-
Health Leaders Convene in Korea to Save Women’s Lives
The International Vaccine Institute (IVI) has convened a symposium of 150 experts, policymakers, and decision makers from more than 36 countries from the Asia-Pacific and Middle East regions. This is to develop solutions to expand vaccination program…
Institute | 11 June 2009
-
National Cancer Institute Buys UPLC/MS Systems from Waters
The National Cancer Institute's Center for Cancer Research in Bethesda, US, has purchased the Acquity UPLCR/Synapt High Definition MS (HDMST) and UPLC/XevoT TQ MS systems from Waters for its metabolomics research programs. The research is aimed a…
Institute | 14 April 2009
